
Xenon Pharmaceuticals (NASDAQ:XENE) brought in sales totaling $3.74 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 65.52%, resulting in a loss of $25.56 million. In Q3, Xenon Pharmaceuticals brought in $8.12 million in sales but lost $15.45 million in earnings.